#ESC22: In re­turn to ‘big chron­ic dis­eases,’ Eu­rope’s car­dio con­fab show­cas­es mixed bag of da­ta drops

BARCELONA — For the first time dur­ing Covid-19, 30,000 car­di­ol­o­gists, bio­phar­ma lead­ers and tri­al in­ves­ti­ga­tors met in per­son for the Eu­ro­pean So­ci­ety of Car­di­ol­o­gy Con­gress.

The 71st edi­tion in­clud­ed all the bells and whis­tles of a mas­sive sci­en­tif­ic con­fer­ence, al­beit with no phys­i­cal “posters” in sight — at­ten­dees could ac­cess the lat­est in­sights through dig­i­tal kiosks in the “Re­search Gate­way.” Sci­en­tists from more than 80 coun­tries pre­sent­ed ab­stracts, to­tal­ing 3,218, ESC said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER